COVID-19 is an emerging, rapidly evolving situation.

Get the latest public health information from CDC: https://www.coronavirus.gov
Get the latest research information from NIH: https://www.nih.gov/coronavirus
NIH staff guidance on coronavirus (NIH Only)

FPRS - Transition from Acute to Chronic Pain

Ted Price, PhD (Co-Chair)

University of Texas at Dallas

Ted Price, PhD, performs research focused on molecular mechanisms driving the transition to chronic pain with an increasing focus on drug development for chronic pain disease modification.
Read More

Bob Dworkin, PhD (Co-chair)

University of Rochester

The primary focus of Dr. Dworkin’s current research involves methodologic aspects of analgesic clinical trials, especially identifying factors that might increase the assay sensitivity of a trial to detect differences between an active and a control or comparison treatment.
Read More

Jackie Bresnehan, PhD

University of California San Francisco

Dr. Bresnahan's research focuses on understanding the biological underpinnings of neurotrauma, particularly spinal cord injury, with the goal of improving recovery for individuals who suffer damage to the nervous system.
Read More

Jan Chambers *

National Fibromyalgia & Chronic Pain Association

President

Jan Favero Chambers is president of the National Fibromyalgia & Chronic Association (NFMCPA), a not for profit, 501c3 organization whose mission is to build a united patient and medical community that will execute advocacy programs regarding access to care, scientific research, diagnosis and treatment for people suffering with fibromyalgia and chronic pain.

Read More

Yves De Koninck, PhD

Laval University

Dr. De Koninck Studies nervous signal transmission using state of the art techniques with the aim of alleviating chronic pain.
Read More

Ru-Rong Ji, PhD

Duke University

Ru-Rong has been doing pain and neuroscience research for more than 20 years. His current research focuses on chronic pain mechanisms and development of novel pain therapeutics.
Read More

Joel Katz, PhD

York University

Dr. Katz’s research is focused on assessing the contribution of peripheral injury to the development of pathological pain states in which the central nervous system plays a prominent role. He is also interested in designing and systematically evaluating means of preventing the state of central neural sensitization that develops after injury and that often marks the transition from time-limited pain to chronic pathological pain.
Read More

Annemieke Kavelaars, PhD

University of Texas, MD Anderson

Dr. Kavelaar’s work is focused on the broad field of nervous system-immune system interactions. Her most recent studies aim at understanding the endogenous neuroimmune mechanisms that govern resolution of pain.
Read More

Jon Levine MD, PhD

University of California San Francisco

Dr. Levine’s research focuses include Signal Transduction and Second Messenger Signaling in Pain Sensory Neurons; CNS Pain Control Mechanisms; Neural-Endocrine Control of Inflammation.
Read More

Neil Schechter, MD

Boston Children’s Hospital

Dr. Schechter’s research focus has been primarily on common pain problems in pediatric practice, functional pain, hypermobility syndromes, and strategies to promote institutional change regarding pain.
Read More

Kathleen Sluka, PT PhD

University of Iowa

Professor of Physical Therapy and Rehabilitation Science
Kathleen Sluka, PT, PhD, FAPTA is a Professor of Physical Therapy and Rehabilitation Science at the University of Iowa. Dr. Sluka’s lab studies the peripheral and central mechanisms of chronic musculoskeletal pain, and non-pharmacological treatment for chronic pain.
Read More

Greg Terman, MD

University of Washington

His research focuses on neuroplasticity associated with pain and opioids - including mechanisms of central sensitization, opiate tolerance, itch and respiratory depression. Although his research has been primarily pre-clinical, including slice physiology and behavioral pharmacology, he has also been involved in clinical studies in human volunteers and patients.
Read More

Tor Wager, PhD

University of Colorado

The Wager lab’s research focuses on the brain mechanisms underlying pain, emotion, and stress. The lab’s research emphasizes developing brain markers for these affective processes and using them to understand the effects of psychological and pharmacological interventions, including effects of placebo, expectancy, self-regulation, and opioids. Dr. Wager is also actively involved in developing new analysis methods for human neuroimaging and other complex multivariate datasets.
Read More

Tony Yaksh, PhD

University of California San Diego

The goal of my work is to understand the encoding process for nociceptive information to permit development of pharmacological therapies for the management of pain. A continuing thread of this ongoing work (>200 papers) has been the contribution of neuraxial innate immune signaling and the cascades that mediate the transition from an acute inflammation to a chronic neuropathic like pain state.
Read More

Audrey Kusiak, PhD (non-voting member)

VA representative to IPRCC

Martha Matocha, PhD (non-voting member)

NIH Pain Consortium


Khara Ramos, PhD (non-voting member)

NINDS

OPP Liaison